Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...
The Efficacy and Safety of Triple Therapy in Obstructive Lung Disease (ETHOS) and Informing the Pathway of Chronic ...
Hosted on MSN
Long-acting β-agonist use not tied to increased severity of oral food challenge reactions
THURSDAY, March 12, 2026 (HealthDay News) -- Reaction severity does not significantly differ between children with food allergy and asthma failing an oral food challenge (OFC) who are taking inhaled ...
A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to Novartis’ ...
Novartis has moved a step closer to EU approval of its three-drug asthma therapy Enerzair Breezhaler, and now looks set to beat a rival therapy from GlaxoSmithKline to market. Enerzair (formerly ...
Stria Lithium, Inc. is a resource exploration company, which engages in the business of acquiring and developing mineral properties with the aim of discovering commercially exploitable lithium ...
Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch ...
Key updates in the 2025 GOLD report. PH: pulmonary hypertension; GLI: Global Lung Function Initiative; BNP: brain natriuretic peptide; ICS: inhaled corticosteroid(s); LABA: long-acting β2 agonist; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results